Pamela J. McLean, Ph.D.
Affiliations: | Neuroscience | Mayo Clinic Florida |
Area:
Parkinson's disease, alpha-synucleinGoogle:
"Pamela J. McLean"Mean distance: 106866
Parents
Sign in to add mentor| David H. Farb | grad student | 1990-1997 | Boston University |
| Bradley T. Hyman | post-doc | 1997-2012 | MGH |
Children
Sign in to add trainee| Hibiki Kawamata | research assistant | 1999-2001 | MGH & Harvard Medical School |
| Jessie St. Martin | research assistant | 2003-2007 | MGH & Harvard Medical School |
| Preeti Putcha | research assistant | 2007-2009 | MGH & Harvard Medical School |
| Natasha N DeMeo | research assistant | 2016-2018 | Mayo Clinic Jacksonville |
| Jeremy D. Burgess | grad student | 2016- | Mayo Clinic Florida |
| Ayman H. Faroqi | grad student | 2019- | Mayo Clinic Graduate School of Biomedical Sciences |
| Julie Tetzlaff | post-doc | 2006-2009 | MGH & Harvard Medical School |
| Nikolaus R. McFarland | post-doc | 2006-2010 | Mayo Clinic Florida |
| Lorraine Kalia | post-doc | 2009-2010 | MGH & Harvard Medical School |
| Karin Danzer | post-doc | 2008-2011 | MGH & Harvard Medical School |
| Hemi Dimant | post-doc | 2010-2013 | MGH & Harvard Medical School |
| Ashley Winslow | post-doc | 2011-2013 | MGH & Harvard Medical School |
| Daryl Jones | post-doc | 2012-2014 | Mayo Clinic Florida |
| Simon Moussaud | post-doc | 2012-2015 | Mayo Clinic Florida |
| Ming Gan | post-doc | 2013-2016 | Mayo Clinic Florida |
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Jin Y, Li F, Li Z, et al. (2024) Modeling Lewy body disease with triplication iPSC-derived cortical organoids and identifying therapeutic drugs. Science Advances. 10: eadk3700 |
| Gupta K, Perkerson RB, Parsons TM, et al. (2024) Secretome from iPSC-derived MSCs exerts proangiogenic and immunosuppressive effects to alleviate radiation-induced vascular endothelial cell damage. Stem Cell Research & Therapy. 15: 230 |
| Agarwal K, Backler W, Bayram E, et al. (2024) Lewy body dementia: Overcoming barriers and identifying solutions. Alzheimer's & Dementia : the Journal of the Alzheimer's Association |
| Burgess JD, Amerna D, Norton ES, et al. (2023) A mutant methionyl-tRNA synthetase-based toolkit to assess induced-mesenchymal stromal cell secretome in mixed-culture disease models. Stem Cell Research & Therapy. 14: 289 |
| Basu S, Song M, Adams L, et al. (2023) Transcriptional mutagenesis of α-synuclein caused by DNA oxidation in Parkinson's disease pathogenesis. Acta Neuropathologica |
| Fagen SJ, Burgess JD, Lim MJ, et al. (2023) Honokiol decreases alpha-synuclein mRNA levels and reveals novel targets for modulating alpha-synuclein expression. Frontiers in Aging Neuroscience. 15: 1179086 |
| Kaya ZB, Karakoc E, McLean PJ, et al. (2023) Post-inflammatory administration of -acetylcysteine reduces inflammation and alters receptor levels in a cellular model of Parkinson's disease. Faseb Bioadvances. 5: 263-276 |
| Hou X, Chen TH, Koga S, et al. (2023) Alpha-synuclein-associated changes in PINK1-PRKN-mediated mitophagy are disease context dependent. Brain Pathology (Zurich, Switzerland). e13175 |
| Burgess JD, Amerna D, Norton ES, et al. (2023) A Mutant Methionyl-tRNA Synthetase-Based toolkit to assess induced-Mesenchymal Stromal Cell secretome in mixed-culture disease models. Research Square |
| Kolicheski A, Turcano P, Tamvaka N, et al. (2022) Early-Onset Parkinson's Disease: Creating the Right Environment for a Genetic Disorder. Journal of Parkinson's Disease. 12: 2353-2367 |